Kexing Biopharm Co., Ltd. (SHA:688136)

China · Delayed Price · Currency is CNY

30.06

-1.07 (-3.44%)

Apr 21, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharmaceutical Manufacturing	1.54B	1.41B	1.26B	1.32B	1.29B
Pharmaceutical Manufacturing Growth	9.54%	11.75%	-4.32%	2.39%	5.32%
Total	1.54B	1.41B	1.26B	1.32B	1.29B
Total Growth	9.54%	11.75%	-4.32%	2.39%	5.32%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
China	829.25M	-	-	-
Export	217.81M	-	-	-
Total	1.05B	-	-	-

Source: S&P Global Market Intelligence.